Summary
The Federal Trade Commission (FTC) is investigating if health providers are not sharing risks or falsely promoting benefits of gender-affirming care, especially regarding minors. The FTC is collecting public input until September 26 to check if such care involves misleading claims.
Key Facts
- The FTC inquiry focuses on health providers' communication about risks and benefits related to gender-affirming care.
- Public comments about potential misleading claims, particularly about minors, are being gathered until September 26.
- The FTC is evaluating if health providers are violating the FTC Act by not fully sharing risks or by making unproven claims.
- Major medical organizations like the American Medical Association support gender-affirming care for minors.
- Treatments such as puberty blockers and hormone therapy are tailored to individual needs; surgeries for minors are uncommon.
- People who had gender-affirming care during adolescence often report satisfaction with their decision as adults.
- The Trump administration took steps against providers offering gender-affirming care to minors, citing fraud and health risks.
- Some hospitals paused such services due to federal investigations and concerns over funding issues.
